Repare Therapeutics Inc reports results for the quarter ended in December - Earnings Summary

Repare Therapeutics

01/03/2023 05:29

* Repare Therapeutics Inc  RPTX.OQ  reported a quarterly
adjusted
loss of 75 cents​​ per share for the quarter ended in December.
The mean expectation of eight analysts for the quarter was for a
loss of 72 cents per share.
    * Revenue rose 164.6% to $18.20 million from a year ago;
analysts
expected $8.12 million. 
    * Repare Therapeutics Inc's reported EPS for the quarter was
a
loss of 75 cents​.
    * The mean earnings estimate of analysts had fallen by
about 4.3%
in the last three months.​ 
    * In the last 30 days two analysts negatively revised
earnings
estimates 
    * Repare Therapeutics Inc shares had fallen by 30.3% this
quarter.
    * The company reported a quarterly loss of $31.13 million.
    * Wall Street's median 12-month price target for Repare
Therapeutics Inc is $28.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data March 1
at 05:29 a.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.72          -0.75          Missed
 Sep. 30 2022      -0.89          1.71           Beat
 Jun. 30 2022      -0.85          -0.91          Missed
 Mar. 31 2022      -0.86          -0.83          Beat